Completing HI observations of galaxies II. The Coma Supercluster

High sensitivity 21-cm HI line observations, with an rms noise level of \sim 0.5 mJy, were made of 35 spiral galaxies in the Coma Supercluster, using the refurbished Arecibo telescope, which resulted in the detection of 25 objects. These data, combined with the measurements available from the literature, provide the set of HI data for 94% of all late-type galaxies in the Coma Supercluster with an apparent photographic magnitude m_p <15.7 mag. We confirm that the typical scale of HI deficiency around the Coma cluster is 2 Mpc, i.e. one virial radius. Comparing the HI mass function (HIMF) of cluster with non-cluster members of the Coma Supercluster we detect a shortage of high HI mass galaxies among cluster members that can be ascribed to the pattern of HI deficiency found in rich clusters.Comment: 16 pages, 8 figures, 4 tables. Accepted for publication on A&

The characteristics of electronic training collars for dogs

A wide range of electronic dog training collars (e-collars) is available in the UK, yet there is no means by which purchasers can meaningfully compare their electrical characteristics at the point of sale. In this research the electrical characteristics of 13 models of e-collar were examined and an approach to ranking the strength of the electrical stimuli was developed. The electrical impedance of dogs’ necks was measured so that e-collars could be tested under realistic conditions. This impedance was found to be about 10kΩ for wet dogs and 640kΩ for dry dogs. Two copies of each of eight e-collar models and one copy of a further five models were tested. The stimuli generated by these collars comprised sequences of short high voltage pulses. There were large differences between e-collar models in the peak voltage, number of pulses and duration of the pulses but little variation between the duplicates. The peak voltage varied with the impedance of the dog, from 6000V at an impedance of 500kΩ to 100V at 5kΩ. The highest voltages were generated for only a few millionths of a second. A stimulus strength ranking index (SSRI) was developed based on the subjective response of human subjects to electrical stimuli. This index is used to compare the strength of e-collars with diverse electrical characteristics. It shows a wide range in the stimulus strengths of collars and that the relationships between ‘momentary’ and ‘continuous’ stimuli for various models differ significantly

Signatures of Interchange Reconnection: STEREO, ACE and Hinode Observations Combined

Combining STEREO, ACE and Hinode observations has presented an opportunity to follow a filament eruption and coronal mass ejection (CME) on the 17th of October 2007 from an active region (AR) inside a coronal hole (CH) into the heliosphere. This particular combination of `open' and closed magnetic topologies provides an ideal scenario for interchange reconnection to take place. With Hinode and STEREO data we were able to identify the emergence time and type of structure seen in the in-situ data four days later. On the 21st, ACE observed in-situ the passage of an ICME with `open' magnetic topology. The magnetic field configuration of the source, a mature AR located inside an equatorial CH, has important implications for the solar and interplanetary signatures of the eruption. We interpret the formation of an `anemone' structure of the erupting AR and the passage in-situ of the ICME being disconnected at one leg, as manifested by uni-directional suprathermal electron flux in the ICME, to be a direct result of interchange reconnection between closed loops of the CME originating from the AR and `open' field lines of the surrounding CH.Comment: 13 pages, 13 figures, accepted Annales Geophysica

Spin drag Hall effect in a rotating Bose mixture

We show that in a rotating two-component Bose mixture, the spin drag between the two different spin species shows a Hall effect. This spin drag Hall effect can be observed experimentally by studying the out-of-phase dipole mode of the mixture. We determine the damping of this mode due to spin drag as a function of temperature. We find that due to Bose stimulation there is a strong enhancement of the damping for temperatures close to the critical temperature for Bose-Einstein condensation.Comment: 1 figur

Proceedings of the International Workshop on: methods and tools for water-related adaptation to climate change and climate proofing

The workshop fits in the National Water Plan of the Netherlands’ government of which the international chapter includes the strengthening of cooperation with other delta countries, including Indonesia, Vietnam and Bangladesh and is part of the work plan of the Cooperative Programme on Water and Climate, a Netherlands’ sponsored programme with the objective to improve knowledge and capacity on the relation between water and climate change especially in developing countries and countries in transition

Nasal decongestants in monotherapy for the common cold

Background : Many treatments for the common cold exist and are sold over-the-counter. Nevertheless, evidence on the effectiveness and safety of nasal decongestants is limited. Objectives : To assess the efficacy, and short-and long-termsafety, of nasal decongestants used inmonotherapy to alleviate symptoms of the common cold in adults and children. Search methods : We searched the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 6, June 2016), which contains the Cochrane Acute Respiratory Infections (ARI) Specialised Register, MEDLINE (1946 to July 2016), Embase (2010 to 15 July 2016), CINAHL (1981 to 15 July 2016), LILACS (1982 to July 2016), Web of Science (1955 to July 2016) and clinical trials registers. Selection criteria : Randomised controlled trials (RCTs) and cluster-RCTs investigating the effectiveness and adverse effects of nasal decongestants compared with placebo for treating the common cold in adults and children. We excluded quasi-RCTs. Data collection and analysis : Three review authors independently extracted and summarised data on subjective measures of nasal congestion, overall patient wellbeing score, objective measures of nasal airway resistance, adverse effects and general recovery. One review author acted as arbiter in cases of disagreement. We categorised trials as single and multi-dose and analysed data both separately and together. We also analysed studies using an oral or topical nasal decongestant separately and together. Main results : We included 15 trials with 1838 participants. Fourteen studies included adult participants only (aged 18 years and over). In six studies the intervention was a single dose and in nine studies multiple doses were used. Nine studies used pseudoephedrine and three studies used oxymetazoline. Other decongestants included phenylpropanolamine, norephedrine and xylometazoline. Phenylpropanolamine (or norephedrine) is no longer available on the market therefore we did not include the results of these studies in the meta-analyses. Eleven studies used oral decongestants; four studies used topical decongestants. Participants were included after contracting the common cold. The duration of symptoms differed among studies; in 10 studies participants had symptoms for less than three days, in three studies symptoms were present for less than five days, one study counted the number of colds over one year, and one study experimentally induced the common cold. In the single-dose studies, the effectiveness of a nasal decongestant was measured on the same day, whereas the follow-up in multi-dose studies ranged between one and 10 days. Most studies were conducted in university settings (N = eight), six at a specific university common cold centre. Three studies were conducted at a university in collaboration with a hospital and two in a hospital only setting. In two studies the setting was unclear. There were large differences in the reporting of outcomes and the reporting of methods in most studies was limited. Therefore, we judged most studies to be at low or unclear risk of bias. Pooling was possible for a limited number of studies only; measures of effect are expressed as standardised mean differences (SMDs). A positive SMD represents an improvement in congestion. There is no defined minimal clinically important difference for measures of subjective improvement in nasal congestion, therefore we used the SMDs as a guide to assess whether an effect was small (0.2 to 0.49), moderate (0.5 to 0.79) or large (>= 0.8). Single-dose decongestant versus placebo: 10 studies compared a single dose of nasal decongestant with placebo and their effectiveness was tested between 15 minutes and 10 hours after dosing. Seven of 10 studies reported subjective symptom scores for nasal congestion; none reported overall patient well-being. However, pooling was not possible due to the large diversity in the measurement and reporting of symptoms of congestion. Two studies recorded adverse events. Both studies used an oral decongestant and each of them showed that there was no statistical difference between the number of adverse events in the treatment group versus the placebo group. Multi-dose decongestant versus placebo: nine studies compared multiple doses of nasal decongestants with placebo, but only five reported on the primary outcome, subjective symptom scores for nasal congestion. Only one study used a topical decongestant; none reported overall patient well-being. Subjective measures of congestion were significantly better for the treatment group compared with placebo approximately three hours after the last dose (SMD 0.49, 95% confidence interval (CI) 0.07 to 0.92; P = 0.02; GRADE: low-quality evidence). However, the SMD of 0.49 only indicates a small clinical effect. Pooling was based on two studies, one oral and one topical, therefore we were unable to assess the effects of oral and topical decongestants separately. Seven studies reported adverse events (six oral and one topical decongestant); meta-analysis showed that there was no statistical difference between the number of adverse events in the treatment group (125 per 1000) compared to the placebo group (126 per 1000). The odds ratio (OR) for adverse events in the treatment group was 0.98 (95% CI 0.68 to 1.40; P = 0.90; GRADE: low-quality evidence). The results remained the same when we only considered studies using an oral decongestant (OR 0.95, 95% CI 0.65 to 1.39; P = 0.80; GRADE: low-quality evidence). Authors' conclusions : We were unable to draw conclusions on the effectiveness of single-dose nasal decongestants due to the limited evidence available. For multiple doses of nasal decongestants, the current evidence suggests that these may have a small positive effect on subjective measures of nasal congestion in adults with the common cold. However, the clinical relevance of this small effect is unknown and there is insufficient good-quality evidence to draw any firm conclusions. Due to the small number of studies that used a topical nasal decongestant, we were also unable to draw conclusions on the effectiveness of oral versus topical decongestants. Nasal decongestants do not seem to increase the risk of adverse events in adults in the short term. The effectiveness and safety of nasal decongestants in children and the clinical relevance of their small effect in adults is yet to be determined

Current-driven and field-driven domain walls at nonzero temperature

We present a model for the dynamics of current- and field-driven domain-wall lines at nonzero temperature. We compute thermally-averaged drift velocities from the Fokker-Planck equation that describes the nonzero-temperature dynamics of the domain wall. As special limits of this general description, we describe rigid domain walls as well as vortex domain walls. In these limits, we determine also depinning times of the domain wall from an extrinsic pinning potential. We compare our theory with previous theoretical and experimental work